Researcher
Sana Arnouk
- Keywords (Vrije Universiteit Brussel):Applied biological sciences, biotechnology
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Vrije Universiteit Brussel):Applied immunology, Cancer therapy
- See also: Sana Arnouk (Vrije Universiteit Brussel)
Affiliations
- Department of Bio-engineering Sciences (Department)
Member
From1 Jan 2024 → Today - Cellular and Molecular Immunology (Research group)
Member
From1 Nov 2023 → 31 Dec 2023 - Department of Bio-engineering Sciences (Department)
Member
From1 Nov 2019 → 31 Oct 2023 - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → 31 Oct 2019 - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From30 Oct 2018 → 19 Dec 2023 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2018 → 31 Oct 2019 - Van Ginderachter Lab (Research group)
Member
From1 Oct 2018 → Today - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From30 Sep 2016 → 13 Sep 2018
Publications
1 - 10 of 10
- Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.(2023)
Authors: Sana Arnouk, Kiavash Movahedi, Cécile Vincke, Jo Van Ginderachter
Pages: 355-373 - Imaging and therapeutic targeting of the tumor immune microenvironment with biologics.(2022)
Authors: Sana Arnouk, Jo Van Ginderachter
Pages: 114239 - Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.(2022)
Authors: Aleksandar Murgaski, Mate Kiss, Helena Van Damme, Daliya Kancheva, Eva Hadadi, Sana Arnouk, Victor Bosteels, Niels Vandamme, Sofie Deschoemaeker, Sophie Janssens, et al.
Pages: 3785-3801 - Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.(2022)
Authors: Mate Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Isabelle Scheyltjens, Pauline Bardet, Sana Arnouk, Jo Van Ginderachter, Damya Laoui
Pages: 1003975 - IL1ß promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin.(2021)
Authors: Mate Kiss, Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, Pauline Bardet, Sana Arnouk, et al.
Pages: 309-323 - Targeted Repolarization of Tumor-Associated Macrophages via Imidazoquinoline-Linked Nanobodies.(2021)
Authors: Evangelia Bolli, Sana Arnouk, Ana Rita Pombo Antunes, Karen De Vlaminck, Kiavash Movahedi, Jo Van Ginderachter
Pages: 2004574 - Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels.(2020)
Authors: Evangelia Bolli, Ana Rita Pombo Antunes, Sana Arnouk, Jo Van Ginderachter
Pages: E2222 - Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.(2020)
Authors: Els Lebegge, Sana Arnouk, Pauline Bardet, Mate Kiss, Geert Raes, Jo Van Ginderachter
Pages: 1395 - Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-Delivery(2019)
Authors: Aleksandar Murgaski, Pauline Bardet, Sana Arnouk, Emile Clappaert, Damya Laoui
Pages: E670 - Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors.(2019)
Authors: Evangelia Bolli, Aleksandar Murgaski, Emile Clappaert, Sana Arnouk, Ana Rita Pombo Antunes, Amanda Gonçalves, Geert Raes, Kiavash Movahedi, Jo Van Ginderachter
Pages: 1-11